SUCCESS STORIES
Swiss Industry &
Global Health
Driving innovation. Opening markets. Strengthening the location. Concrete examples of how international research and development partnerships enable Swiss innovations with global impact.
NOVARTIS
Innovation through
global partnerships
With Coartem Baby, Novartis, together with the Geneva-based Product Development Partnership Medicines for Malaria Venture (MMV), developed the world's first malaria therapy specifically designed for newborns and young infants. The development took place within the international PAMAfrica consortium, co-financed by EDCTP and Sida. The clinical trial was conducted at several sites in Africa, with the participation of the Swiss TPH and the Ifakara Health Institute in Tanzania.
ROCHE
International Geneva
as a catalyst
Roche's collaboration with the World Health Organization (WHO) on the prequalification of diagnostic tests paved the way for their procurement through the Global Fund and other international programmes. For example, Roche's HIV diagnostics have been incorporated into national health programmes around the world, improving access to reliable diagnosis for millions of people.
VESTERGAARD
Swiss materials technology with global impact
The Swiss company Vestergaard develops innovative technologies for malaria prevention. With PermaNet Dual, Vestergaard has developed a next-generation mosquito net that uses two active ingredients to specifically combat increasing insecticide resistance. Following a recommendation from the WHO, the technology was scaled up in collaboration with the Global Fund to improve access in malaria-endemic areas.
FERRING PHARMACEUTICALS
Opportunities for companies of every size
Swiss SMEs also benefit from global partnerships: Together with Geneva-based Concept Foundation and UNFPA, Ferring Pharmaceuticals (Saint-Prex) is working to prevent life-threatening postpartum haemorrhage; an example of how international collaboration helps bring Swiss innovations into global health programmes.
MOMM Diagnostics · Innosuisse · Venture Kick
From Swiss start-up to global innovation
Basel-based start-up MOMM Diagnostics is developing innovative diagnostics for pregnancy complications that have the potential to reduce maternal mortality, particularly in low-income countries. The company is supported by Switzerland's innovation ecosystem, including Innosuisse, Venture Kick, and one of the world's leading life sciences networks.
SYNGENTA
Global health goes
beyond pharma
Syngenta (Basel) develops innovative active ingredients and insecticides to combat disease-transmitting insects. Its products are used worldwide in programmes to prevent malaria and other vector-borne diseases. In doing so, the company makes an important contribution to controlling disease-transmitting mosquitoes.
FACTS & FIGURES